PortfoliosLab logoPortfoliosLab logo
Roche Holding AG (RHHBY)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US7711951043

Highlights

EPS (TTM)
$5.42
PE Ratio
9.17
Total Revenue (TTM)
$107.65B
Gross Profit (TTM)
$79.28B
EBITDA (TTM)
$31.01B
Year Range
$34.75 - $60.85
Target Price
$57.00
ROA (TTM)
17.27%
ROE (TTM)
51.44%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Roche Holding AG, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Roche Holding AG (RHHBY) has returned -0.56% so far this year and 24.62% over the past 12 months. Over the last ten years, RHHBY has returned 8.21% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Roche Holding AG

1D
1.78%
1M
-13.88%
YTD
-0.56%
6M
22.66%
1Y
24.62%
3Y*
15.46%
5Y*
7.60%
10Y*
8.21%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 2, 2001, RHHBY's average daily return is +0.04%, while the average monthly return is +0.85%. At this rate, your investment would double in approximately 6.8 years.

Historically, 55% of months were positive and 45% were negative. The best month was Mar 2009 with a return of +25.4%, while the worst month was Feb 2009 at -20.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.

On a daily basis, RHHBY closed higher 46% of trading days. The best single day was May 8, 2001 with a return of +13.6%, while the worst single day was Mar 17, 2003 at -13.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202610.04%4.93%-13.88%-0.56%
202512.53%6.34%1.93%-0.92%-1.15%1.14%-4.54%4.78%2.55%-3.37%18.39%7.82%52.86%
2024-3.01%-6.86%1.53%-6.58%7.34%8.31%16.84%4.49%-5.62%-2.85%-6.62%-3.75%0.23%
2023-0.00%-7.92%3.17%9.37%0.94%-3.51%1.31%-5.35%-7.37%-4.72%4.21%7.54%-4.02%
2022-6.00%-2.80%7.44%-6.54%-7.88%-1.95%-0.58%-2.48%0.45%1.77%-1.02%-4.33%-22.21%
2021-0.98%-5.32%0.61%0.37%7.49%7.38%2.70%4.06%-9.46%6.29%0.93%5.97%20.20%

Benchmark Metrics

Roche Holding AG has an annualized alpha of 7.30%, beta of 0.48, and R² of 0.15 versus S&P 500 Index. Calculated based on daily prices since January 03, 2001.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (62.27%) than losses (50.02%) — typical of diversified or defensive assets.
  • Beta of 0.48 may look defensive, but with R² of 0.15 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.15 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
7.30%
Beta
0.48
0.15
Upside Capture
62.27%
Downside Capture
50.02%

Return for Risk

Risk / Return Rank

RHHBY ranks 66 for risk / return — better than 66% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


RHHBY Risk / Return Rank: 6666
Overall Rank
RHHBY Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
RHHBY Sortino Ratio Rank: 6565
Sortino Ratio Rank
RHHBY Omega Ratio Rank: 6262
Omega Ratio Rank
RHHBY Calmar Ratio Rank: 6565
Calmar Ratio Rank
RHHBY Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Roche Holding AG (RHHBY) and compare them to a chosen benchmark (S&P 500 Index).


RHHBYBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.86

0.90

-0.04

Sortino ratio

Return per unit of downside risk

1.40

1.39

+0.01

Omega ratio

Gain probability vs. loss probability

1.17

1.21

-0.04

Calmar ratio

Return relative to maximum drawdown

1.16

1.40

-0.24

Martin ratio

Return relative to average drawdown

3.75

6.61

-2.85

Explore RHHBY risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Roche Holding AG provided a 3.20% dividend yield over the last twelve months, with an annual payout of $1.59 per share. The company has been increasing its dividends for 6 consecutive years.


1.50%2.00%2.50%3.00%3.50%4.00%$0.00$0.20$0.40$0.60$0.80$1.00$1.20$1.4020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$1.59$1.39$1.35$1.29$1.27$0.81$0.73$0.69$1.11$1.03$1.02$1.00

Dividend yield

3.20%2.69%3.87%3.55%3.23%1.57%1.66%1.70%3.58%3.25%3.57%2.91%

Monthly Dividends

The table displays the monthly dividend distributions for Roche Holding AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$1.59$1.59
2025$0.00$0.00$1.39$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.39
2024$0.00$0.00$1.35$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.35
2023$0.00$0.00$1.29$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.29
2022$0.00$0.00$1.27$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.27
2021$0.00$0.00$0.81$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.81

Dividend Yield & Payout


Dividend Yield

Roche Holding AG has a dividend yield of 3.20%, which is quite average when compared to the overall market.

Payout Ratio

Roche Holding AG has a payout ratio of 73.07%, which is quite average when compared to the overall market. This suggests that Roche Holding AG strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Roche Holding AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Roche Holding AG was 45.73%, occurring on Mar 2, 2009. Recovery took 567 trading sessions.

The current Roche Holding AG drawdown is 15.35%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-45.73%Feb 29, 2008253Mar 2, 2009567May 31, 2011820
-40.88%Apr 11, 2022518May 2, 2024388Nov 18, 2025906
-40.69%Jan 5, 2001548Mar 17, 2003193Dec 18, 2003741
-27.32%Jun 1, 2015387Dec 8, 2016555Feb 26, 2019942
-20.28%Feb 20, 202016Mar 12, 202028Apr 22, 202044

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Roche Holding AG over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Roche Holding AG is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for RHHBY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/E ratio of 9.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for RHHBY relative to other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items